Alexion Pharmaceuticals’ $930 Million Acquisition of Achillion Pharmaceuticals

Ambrogio Visconti

Foley Hoag LLP assisted Alexion Pharmaceuticals Inc in the transaction. Alexion Pharmaceuticals (NASDAQ:ALXN) executed the acquisition of biotech Achillion Pharmaceuticals Inc (NASDAQ:ACHN). The initial consideration of…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

…

This content is for Standard 1 Year members only.
Login Join Now